文献速递心外重症与机械循环支持

耐用型心室辅助装置应用与价值评估路线图

A roadmap for evaluating the use and value of durable ventricular assist device therapy.
PubMed 文献 · J Heart Lung Transplant · 2017-06-23

该文指出心衰患者常需心脏移植或植入左心室辅助装置(LVAD)以延长生存并改善生活质量,但供体、中心经验与合并症限制移植可行性,LVAD应用增多。作者提出整合技术、保险覆盖、市场、提供者与患者层面因素的概念模型,作为理解LVAD使用与价值(质量除以成本)的必要前提。

要点

  • LVAD可作为移植桥接或永久治疗,数据已证实其改善生存、功能状态与生活质量。
  • 现有研究较少关注LVAD使用的决定因素、其与价值的关系及脆弱人群的影响。
  • 作者提出整合技术、保险、市场、提供者与患者因素的概念模型以指导未来研究。

核心结论

  • 提出整合多层面决定因素的概念模型,是理解LVAD使用与价值的必要前提。

研究设计与样本

  • 本文为概念性综述/路线图,未报告系统检索范围或样本量。

主要发现

  • LVAD植入因供体有限、中心经验与合并症限制而更常用于移植桥接或永久治疗。
  • 较多数据记录LVAD改善生存、功能状态与生活质量。
  • 较少研究聚焦LVAD使用的决定因素、其与价值的关系及脆弱人群的影响。

临床怎么用

  • 临床与政策制定者可参考该概念模型,从技术、保险、市场、提供者与患者层面评估LVAD使用与价值。

局限性

  • 本文为概念性框架,未提供原始数据或系统评价,需未来研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Heart failure is a disease characterized by profound human suffering with limitations in survival despite treatment with guideline-directed medical therapies. Patients with heart failure frequently progress to advanced stages and often require cardiac transplantation or implantation of left ventricular assist devices (LVADs) to extend survival and improve quality of life. As the number of suitable heart donors, number of experienced medical centers and patient comorbidities place restrictions on the feasibility of cardiac transplantation, implantation of LVADs has emerged as a more frequently applied treatment as either a bridge to transplantation or as permanent therapy. Considerable data have documented improvements in survival, functional status and quality of life offered by LVADs, however, few studies have focused on identifying: (1) determinants of LVAD use across medical centers, (2) the relationship between the determinants of LVAD use and value (defined as quality divided by cost), and (3) how determinants of LVAD use are influenced or impacted by vulnerable populations. We propose a conceptual model that integrates the main determinants of LVAD utilization, which include technology, insurance coverage, market-, provider- and patient-level factors. We propose this paradigm as a necessary prerequisite for understanding LVAD usage and value. This conceptual framework provides a broader view for future studies, which are needed to inform emerging healthcare policies that influence dissemination of this expensive but life-prolonging medical therapy.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Ward ST, Liang Q, Pagani FD, et al. A roadmap for evaluating the use and value of durable ventricular assist device therapy. J Heart Lung Transplant. 2017. PMID: 28711453. doi:10.1016/j.healun.2017.06.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。